Robin
L.
Teskin

2318 Mill RoadSuite 1100Alexandria,
Virginia22314

Phone:
703.647.5911
Mobile Phone:
703.408.0043
Fax:
703.647.5958

Biography

Ms. Teskin focuses her practice on intellectual property law, with a particular emphasis on patent law in the biotechnology and pharmaceutical industries. Her experience involves all aspects of patent counseling and patent prosecution, including providing freedom-to-operate, due diligence, noninfringement and invalidity opinions. She advises a wide range of clients, including established and start-up biotechnology and pharmaceutical companies and prominent research universities.

Ms. Teskin has about 30 years of patent law experience which includes significant experience in complex patent office proceedings involving multiple parties such as reissue, reexamination, opposition and interference proceedings. Through her representation of a major pharmaceutical company at the forefront of drug formulation research, she also has an extensive background in Hatch-Waxman legal issues.

Prior to her admission to the bar, Ms. Teskin served as a patent examiner at the U.S. Patent and Trademark Office, where she was a member of the Biotechnology Group. She issued over four hundred-fifty patents dealing with complex biotechnology research and received a Bronze Medal for distinguished federal service.

Representative Experience

Managed patent prosecution worldwide on behalf of prominent biotech company involved in therapeutic antibody development including intellectual property relating to a chimeric antibody approved for the treatment of non-Hodgkin's lymphoma as well as a radiolabelled antibody approved for the treatment of cancer.

Represented prominent research university in an interference at the patent and trademark office and the Federal Circuit relating to a therapeutic antibody approved for the treatment of autoimmune disorders.

Drafted and prosecuted to issuance first patents directed to cloning and nuclear transfer on behalf of a major research university and its exclusive licensee.

Represented a major research university in an interference matter involving real-time polymerase chain reaction techniques. Obtained a non-interference in fact ruling favorable to the client.

Conducted numerous due diligence investigations, including one involving a major patent acquisition by a pharmaceutical company that resulted in the client acquiring a large patent estate (over 800 patents) and significantly streamlining the portfolio in order to minimize patent costs while maintaining key strategic patents.

Drafted and prosecuted to declaration of interference (4-party) a pioneering patent relating to a cervical cancer vaccine on behalf of a prominent university that was licensed by a prominent biotechnology company.

Prepared and filed numerous patent term extensions for biologics and pharmaceuticals.

Co-represented a company at the forefront of stem cell technology and nuclear transfer cloning in a 3-way interference involving pioneering nuclear transfer cloning technology.

Managed and prosecuted IP portfolio for company at the forefront of taste and olfactory receptor technology, which was one of very few biotechnology companies to successfully go public in 2004.

Manage the IP portfolio for a company involved in therapeutic antibodies, Pichia expression and novel platform technology for producing antibody secreting B cells and high affinity therapeutic antibodies.

Involved in numerous due diligences involving acquisition of IP portfolios of emerging and mid-sized biotechnology companies.

Before sending your email to us, please note and understand the following:

This website provides general information about LeClairRyan, its practice areas and professional staff. It is not intended to provide you with legal advice with respect to a matter that you may have.

Until such time as LeClairRyan has resolved all potential conflicts of interest in accepting your representation and has agreed to be engaged as your legal counsel, you are not represented by LeClairRyan or any of its attorneys and have not become a client of the Firm.

Sending this email or otherwise contacting LeClairRyan does not create an attorney-client relationship. By sending information to us, you are not creating an attorney-client relationship, and no disclosure by you before this firm agrees to represent you will prohibit this firm from representing any person or entity adverse to you.

Only if, and after, LeClairRyan has confirmed to you that it is willing and able to represent you should you, send the Firm any information or documents that you consider private or confidential. Such information will not be treated as private, confidential or otherwise protected from disclosure until LeClairRyan has confirmed that it is able and willing to represent you.

If you choose to ignore this warning and submit any information that you believe or otherwise assert to be confidential or privileged, then by clicking on the “Accept” button, you agree that your submission will not preclude LeClairRyan from representing a client in a matter adverse to you where that information could be used against you.